Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 2738 results found. Search for [ Pharmaceutical ]

Results 1 to 21 of 2738
BusinessToday.In
November 24, 2020
Vardhan says it makes no sense to consider Pfizer as pharma major is yet to get approval in the US. After requisite approvals, US pharma major will have to cater to needs of its own country's population first


BusinessToday.In
November 24, 2020
Serum Institute has tied up with British-Swedish pharmaceutical firm AstraZeneca and the University of Oxford to mass-produce the Covishield vaccine to fight back COVID-19 virus


BusinessToday.In
November 24, 2020
India Stock Market News Updates Today: During the session, Sensex hit a lifetime high of 44,601 and Nifty touched record high of 13,074.


BusinessToday.In
November 23, 2020
Indian Council of Medical Research is working closely with SII for Covishield vaccine trials across 15 centres in India, and would also be funding the clinical trials in the country.


BusinessToday.In
November 23, 2020
Vaccine can be easily manufactured, transported and stored at domestic fridge temperature (2-8 degrees C). This means it can be easily distributed using existing medical facilities such as doctor's surgeries and local pharmacies, allowing for the vaccine to be deployed very rapidly, said Oxford University


BusinessToday.In
November 23, 2020
It has been found that one of the vaccine's dosing regimens may be around 90% effective and if this dosing regime is used, more people could be vaccinated with planned vaccine supply, says AstraZeneca


BusinessToday.In
November 23, 2020
The panel-led by Dravida Munnetra Kazhagam (DMK) lawmaker Kanimozhi Karunanidhi will hear officials of pharmaceutical departments on the status of the COVID-19 vaccine


BusinessToday.In
November 23, 2020
Coronavirus vaccine update: Adar Poonawalla, the CEO of Serum Institute had recently said that his company might sell a two-shot COVID-19 vaccine for around Rs 500-600 for the general public


Reuters
November 22, 2020
Xpressbees has a presence in more than 2,000 towns and cities in India, with more than 1,000 customers across industries


BusinessToday.In
November 21, 2020
Bharat Biotech, the developer of India's indigenous vaccine Covaxin, has said that it is planning to enrol about 2,000 participants each in metros for Phase-3 trials of its COVID-19 vaccine that began earlier this week


BusinessToday.In
November 21, 2020
Pfizer's CEO Albert Bourla confirmed the company's application and said in a video statement,  'It is with great pride and joy - and even a little relief - that I can say that our request for emergency use authorization for our COVID-19 vaccine is now in the FDA's hands.'


Shailendra Shukla
New Delhi, November 21, 2020
WHO removes Remdesivir from list of COVID-19 medicines The World Health Organization said on Friday it has suspended Gilead's remdesivir from its so-called prequalification list, an official list of medicines used as a benchmark for procurement by developing countries, after issuing guidance against its use in hospitalised Covid-19 patients. \"The suspension is a signal to countries that WHO, in compliance with the treatment guidelines, does not recommend countries procure the drug for Covi...


BusinessToday.In
November 21, 2020
Pfizer that its EUA submission is supported by solicited safety data from a randomised subset of approximately 8,000 participants aged 18 years or above and unsolicited safety data from approximately 38,000 trial participants


Anand Adhikari
November 20, 2020
Sources reveal the private bank has an exposure of Rs 90 crore in one of the loan accounts of Pune-based loss-making firm Bilcare Ltd. This loan was converted into a zero coupon non-convertible debenture (NCD) by the bank with no repayments scheduled for the first five years


Associated Press
November 20, 2020
The European commission has sealed deals with several pharmaceutical companies including BioNTech and Pfizer to buy millions of doses of vaccines on behalf of all EU Member States


BusinessToday.In
November 20, 2020
Adar Poonawalla said if things go according to the plan, the coronavirus vaccine will be available for vulnerable populations by January or February. And, in March or April, the vaccine will enter the market for the general public


BusinessToday.In
November 19, 2020
Pharmaceutical industry giant Pfizer and its German partner BioNTech had stated on November 18 that their vaccine candidate was 95 per cent effective in preventing COVID-19 infections during late-stage trials


BusinessToday.In
November 19, 2020
Pfizer stock opened with a gain of 6.73% at Rs 5240 on BSE


BusinessToday.In
November 18, 2020
Pfizer and BioNTech informed that primary efficacy analysis of their coronavirus vaccine candidate showed that it was 95 per cent effective beginning 28 days after the first dose


BusinessToday.In
New Delhi, November 17, 2020
Moderna announced on Monday that its experimental COVID-19 vaccine 'mRNA-1273' was 94.5 per cent effective in preventing coronavirus. The statement was issued on the basis of interim data from a late-stage clinical trial. The announcement makes Moderna the second US-based pharmaceutical giant to have reported exceedingly hopeful results from clinical trials of their respective coronavirus vaccine candidates, after Pfizer vaccine. Watch the video for more.


PAGES 1 OF 137  12345